三个月改良Rankin量表评分决定缺血性卒中后5年累积费用
结果显示5年平均累积费用为117576美元,首年费用最高(38152美元),且3个月mRS评分是卒中后长期费用的独立决定因素。
要点
- 5年人均累积费用117576美元,首年费用38152美元为各年最高。
- 3个月mRS 0分与5分者5年累积费用分别为53578与257486美元,差异显著(p<0.001)。
- 3个月mRS评分可独立预测卒中后长期费用,可用于卫生经济学评价。
核心结论
- 3个月mRS评分在预测卒中后长期费用中起重要作用。
- 按3个月mRS分类的费用估计对卒中照护的卫生经济学评价有价值。
研究设计与样本
- 纳入2011年1月至2013年11月的11136例患者,平均年龄68岁,58%为男性,中位随访3.9年(范围0-5年)。
主要发现
- 5年平均累积费用为117576美元,卒中后第一年费用最高(38152美元),较卒中前一年(8718美元)明显增加。
- 5年平均累积费用按3个月mRS评分差异显著(p<0.001),mRS 0分者为53578美元,mRS 5分者为257486美元。
- 3个月mRS评分是卒中后长期费用的独立决定因素。
关键数值与推荐
- 5年平均累积费用117576美元;第一年费用38152美元;卒中前一年费用8718美元。
- 3个月mRS 0分者5年累积费用53578美元,mRS 5分者257486美元。
- 按3个月mRS评分分组的5年累积费用差异p<0.001。
临床怎么用
- 可将3个月mRS评分用于预估缺血性卒中患者的长期医疗费用。
- 按mRS分类的费用数据可供卒中照护的卫生经济学评价参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Stroke is a devastating and costly disease; however, there is a paucity of information on long-term costs and on how they differ according to 3-month modified Rankin scale (mRS) score, which is a primary outcome variable in acute stroke intervention trials. METHODS: We analyzed a prospective multicenter stroke registry (Clinical Research Collaboration for Stroke in Korea) database through linkage with claims data from the National Health Insurance Service with follow-up to December 2016. Healthcare expenditures were converted into daily cost individually, and annual and cumulative costs up to 5 years were estimated and compared according to the 3-month mRS score. RESULTS: Between January 2011 and November 2013, 11,136 patients were enrolled in the study. The mean age was 68 years, and 58% were men. The median follow-up period was 3.9 years (range 0-5 years). Mean cumulative cost over 5 years was $117,576 (US dollars [USD]); the cost in the first year after stroke was the highest ($38,152 USD), which increased markedly from the cost a year before stroke ($8,718 USD). The mean 5-year cumulative costs differed significantly according to the 3-month mRS score (p < 0.001); the costs for a 3-month mRS score of 0 or 5 were $53,578 and $257,486 USD, respectively. Three-month mRS score was an independent determinant of long-term costs after stroke. CONCLUSIONS: We show that 3-month mRS score plays an important role in the prediction of long-term costs after stroke. Such estimates relating to 3-month mRS categories may be valuable when undertaking health economic evaluations related to stroke care.
引用
- Kim SE, Lee H, Kim JY, et al. Three-month modified Rankin Scale as a determinant of 5-year cumulative costs after ischemic stroke: An analysis of 11,136 patients in Korea. Neurology. 2020. PMID: 32029544. doi:10.1212/WNL.0000000000009034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。